Dana Faber Institute is a clinical research site located in Boston, Massachusetts, United States 02115.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Dana Faber Institute has participated in 1 clinical trials.
Therapeutic areas: Philadelphia Chromosome Positive CML.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana Faber Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana Faber Institute has 1 clinical trials on record. Their work covers Philadelphia Chromosome Positive CML.
Dana Faber Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.